Categories
Health Markets

Akorn, Inc. (NASDAQ:AKRX) received warning letter from the Food and Drug Administration

Akorn, Inc. (NASDAQ:AKRX) said that it received a warning letter from the Food and Drug Administration related to the inspection of its Somerset, New Jersey manufacturing facility in July and August 2018. Akorn said it is committed to the highest standards of quality and compliance and will continue to work collaboratively with the FDA to resolve issues addressed […]

Categories
Business FEATURED Health

AbbVie Inc. (NYSE:ABBV) and Allergan entered into conclusive transaction agreement

AbbVie Inc. (NYSE:ABBV) and Allergan plc announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of approximately $63 billion. AbbVie Inc. (NYSE:ABBV) shares slumped -16.25% to finally closed at $65.70 in last active session.  ABBV’s distance from 20 day simple moving average is […]

Categories
Business Health

Bristol-Myers Squibb Company (NYSE:BMY) provided update on approval process with Celgene Corporation

Bristol-Myers Squibb Company (NYSE:BMY) provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation. The Company remains actively engaged in discussions with the U.S. Federal Trade Commission (“FTC”) on the FTC’s continued review of the proposed transaction. To allow the transaction to close on a timely basis in light of […]

Categories
Business Health

Lehigh Valley Health Network and CVS Health Corporation (NYSE:CVS) announced five-year partnership

Lehigh Valley Health Network and CVS Health Corporation (NYSE:CVS) announced a five-year partnership Monday to share patient data to design programs aimed at lowering costs and improving health outcomes. By sharing data, the two health companies can determine which patients are not picking up medications, which means they’re more likely to get sicker and need […]

Categories
Health Markets

Biotech Decliners to Watch: Affimed, LogicBio Therapeutics, Mustang Bio Inc, Clovis Oncology Inc

Affimed N.V. (NASDAQ:AFMD) declined after announcing clinical data update on lead product candidate AFM13 in CD30+ lymphoma at the ICML 2019. Affimed N.V. (NASDAQ:AFMD), a Healthcare sector firm, traded 1.87 Million shares in last trading session with closing price of $2.91 per share. Company return on investment (ROI) is -43.50%. Stock value has moved between $1.4 – […]

Categories
Health Markets

Biotech Hot Stocks: Minerva Neurosciences Inc, SELLAS Life Sciences Group Inc., Array BioPharma Inc., Histogenics Corporation

Minerva Neurosciences, Inc. (NASDAQ:NERV) seltorexant helped patients fall asleep more quickly and stay asleep for longer, beating placebo and Sanofi’s insomnia med Ambien in a phase 2b study. The Waltham, Massachusetts-based biotech is developing seltorexant with Janssen as an add-on treatment for major depressive disorder and insomnia disorder. While Ambien (zolpidem) activates the GABAA receptor to treat […]

Categories
Business Health

CVS Health Corporation (NYSE:CVS) awarded more than $10 million in 2019 to support youth smoking and e-cigarette prevention strategies

Given the significant increase in the number of teens using e-cigarettes, CVS Health Corporation (NYSE:CVS) announced that it and its charitable foundations will award a total of more than $10 million in 2019 to support youth smoking and e-cigarette prevention strategies and education delivered in classrooms, by clinicians and in communities across the United States. The […]

Categories
Business Health

Hot Healthcare Stock: Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (NYSE:MRK) Executive Ken Frazier said a rule to base the price the U.S. government pays for some prescription drugs in it Medicare program on lower prices in other countries would face legal challenges if adopted. U.S. President Donald Trump said last year that one way his administration would seek to lower drug […]

Categories
Business Health

Pfizer Inc. (NYSE:PFE) received approval from the European Commission for breast cancer drug TALZENNA

Pfizer Inc. (NYSE:PFE) has received approval from the European Commission for its TALZENNA a breast cancer drug. This approval follows the medicine’s approval by the U.S. Food and Drug Administration in October 2018. “Today’s approval of TALZENNA for certain patients with advanced-stage breast cancer and an inherited BRCA mutation is the latest example of our successful […]

Categories
Health

$165 billion Profit Industry of US Tobacco Companies’ Could Hit by FDA Revised “Maximum Nicotine” Policy; Morgan Stanley

The tobacco companies of US would be suffering if the FDA enacts a “maximum nicotine” policy, the approximately $165 billion profit industry of US, according to analysts at Morgan Stanley.  The rating agency Morgan Stanley downgraded the shares of British American Tobacco PLC (NYSE:BTI) to underweight, while retaining an underweight rating on Altria and Imperial […]